Description
Cognoa is a prominent pediatric behavioral health company focused on developing prescription digital therapeutics aimed at the early identification and treatment of behavioral health conditions. By striving to change the standard of care, Cognoa seeks to enhance lifelong outcomes for children. Their lead products include the first digital diagnostic for autism and the first prescription digital therapeutic designed specifically for children diagnosed with autism, both of which have received Breakthrough Device designation from the FDA. Furthermore, Cognoa's AI technology platform is facilitating a pipeline of products that targets additional unmet needs in ADHD and anxiety.
Additional Details
Lives Served
-
Company Size
42
Year Founded
2013
Funding
Not Provided
Contact Details
Website URL
LinkedIn URL
Gallery
No images found!
Video
No url found!
There are no reviews yet.